Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
Study NCT ID:
NCT00216658
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-13
First Submit QC Date:
None
Study First Post Date:
2005-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-01-20
Last Update Post Date:
2011-01-24
Last Update Post Date Type:
ESTIMATED